These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 816197)

  • 1. Drug usage review sample studies in long-term care facilities.
    Stewart JE; Kabat HF; Wertheimer AI
    Am J Hosp Pharm; 1976 Feb; 33(2):138-44. PubMed ID: 816197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nationally mandated drug use reviews to improve patient safety in nursing homes: a natural experiment.
    Briesacher B; Limcangco R; Simoni-Wastila L; Doshi J; Gurwitz J
    J Am Geriatr Soc; 2005 Jun; 53(6):991-6. PubMed ID: 15935022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacy audit: an aid to continuing education.
    Keys PW; Giudici RA; Hirsh DR; Gonzales SM
    Am J Hosp Pharm; 1976 Jan; 33(1):52-5. PubMed ID: 944532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of federal indicators in nursing-home drug-regimen review.
    Shannon RC; De Muth JE
    Am J Hosp Pharm; 1984 May; 41(5):912-6. PubMed ID: 6731451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extent of medication use in U.S. long-term-care facilities.
    Robers PA
    Am J Hosp Pharm; 1988 Jan; 45(1):93-100. PubMed ID: 3126653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conceptual framework for drug usage review, medical audit and other patient care review procedures.
    Stolar MH
    Am J Hosp Pharm; 1977 Feb; 34(2):139-45. PubMed ID: 842543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
    Brown J; Josephson M
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance in health care--the federal government: PSRO.
    Munier WB
    Am J Hosp Pharm; 1974 Jul; 31(7):660-3. PubMed ID: 4605000
    [No Abstract]   [Full Text] [Related]  

  • 10. Health Care Financing Administration--Medicaid program; payments for long-term care facility services. Final rule with request for additional comments.
    Fed Regist; 1980 Feb; 45(37):11806-11. PubMed ID: 10309105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved medication use in long-term care: building on the consultant pharmacist's drug regimen review.
    Harjivan C; Lyles A
    Am J Manag Care; 2002 Apr; 8(4):318-26. PubMed ID: 11950127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A strategy to reduce drug expenditures with a drug utilization review program.
    Hoffmann RP
    Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychotropic prescribing in long-term care facilities: impact of medication reviews and educational interventions.
    Nishtala PS; McLachlan AJ; Bell JS; Chen TF
    Am J Geriatr Psychiatry; 2008 Aug; 16(8):621-32. PubMed ID: 18669940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological analysis of patient's charts in a long-term care hospital.
    Julien JY; Barbeau G
    Can J Hosp Pharm; 1981; 34(2):42-6. PubMed ID: 10309438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and implementation of a comprehensive, criteria-based drug-use review program.
    Todd MW; Keith TD; Foster MT
    Am J Hosp Pharm; 1987 Mar; 44(3):529-35. PubMed ID: 3471089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis.
    Cannon KT; Choi MM; Zuniga MA
    Am J Geriatr Pharmacother; 2006 Jun; 4(2):134-43. PubMed ID: 16860260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification and classification of errors associated with hand-repackaging of medications in long-term care facilities in Germany.
    Gerber A; Kohaupt I; Lauterbach KW; Buescher G; Stock S; Lungen M
    Am J Geriatr Pharmacother; 2008 Oct; 6(4):212-9. PubMed ID: 19028377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medicare and Medicaid; requirements for long term care facilities--HCFA. Final rule.
    Fed Regist; 1991 Sep; 56(187):48826-80. PubMed ID: 10114370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring drug therapy in skilled nursing facility patients.
    Stewart JE; Marttila JK; Kabat HF; Wertheimer AI
    Drug Intell Clin Pharm; 1978 Dec; 12(12):704-9. PubMed ID: 10239707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.